tirzepatide weight loss study shows 47% greater vs. Wegovy New study result 🚨 Tirzepatide

These actions are likely due to the potential of BPC-157 to simulate vasodilatation and angiogenesis (new blood vessel formation) due to its action on peptidergic growth factors such as endothelial growth factor, Consequently, the peptide has demonstrated significant protective effects against gastric mucosal injury in rat models

These are the mistakes that come up most frequently in GLP-1 communities and clinical discussions

So What Does This Mean for Wyoming

Tirzepatide is an FDA-approved drug cited here for interpretation only, and cagrilintide is an investigational compound not approved for any indication anywhere